Circulation. 2017 Jul 18;136(3):e1-e23. doi: 10.1161/CIR.0000000000000510. Epub 2017 Jun 15.
Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3 million deaths per year. Preventive treatment that reduces CVD by even a small percentage can substantially reduce, nationally and globally, the number of people who develop CVD and the costs of caring for them. This American Heart Association presidential advisory on dietary fats and CVD reviews and discusses the scientific evidence, including the most recent studies, on the effects of dietary saturated fat intake and its replacement by other types of fats and carbohydrates on CVD. In summary, randomized controlled trials that lowered intake of dietary saturated fat and replaced it with polyunsaturated vegetable oil reduced CVD by ≈30%, similar to the reduction achieved by statin treatment. Prospective observational studies in many populations showed that lower intake of saturated fat coupled with higher intake of polyunsaturated and monounsaturated fat is associated with lower rates of CVD and of other major causes of death and all-cause mortality. In contrast, replacement of saturated fat with mostly refined carbohydrates and sugars is not associated with lower rates of CVD and did not reduce CVD in clinical trials. Replacement of saturated with unsaturated fats lowers low-density lipoprotein cholesterol, a cause of atherosclerosis, linking biological evidence with incidence of CVD in populations and in clinical trials. Taking into consideration the totality of the scientific evidence, satisfying rigorous criteria for causality, we conclude strongly that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD. This recommended shift from saturated to unsaturated fats should occur simultaneously in an overall healthful dietary pattern such as DASH (Dietary Approaches to Stop Hypertension) or the Mediterranean diet as emphasized by the 2013 American Heart Association/American College of Cardiology lifestyle guidelines and the 2015 to 2020 Dietary Guidelines for Americans.
心血管疾病(CVD)是全球首要致死原因,每年导致 1730 万人死亡。即使预防治疗能将 CVD 降低一小部分比例,也能在国家和全球范围内显著减少发展为 CVD 以及需要照护的人数和成本。这份美国心脏协会关于膳食脂肪与 CVD 的主席报告回顾和讨论了科学证据,包括最新的研究,涉及膳食饱和脂肪摄入及其被其他类型脂肪和碳水化合物替代对 CVD 的影响。总之,降低膳食饱和脂肪摄入量并用多不饱和植物油替代,从而降低 CVD 的随机对照试验结果表明,CVD 降低了约 30%,与他汀类药物治疗的降低幅度相似。许多人群的前瞻性观察性研究表明,较低的饱和脂肪摄入量,加上较高的多不饱和脂肪和单不饱和脂肪摄入量,与较低的 CVD 发生率以及其他主要死亡原因和全因死亡率相关。相反,用精制碳水化合物和糖替代饱和脂肪与较低的 CVD 发生率无关,且在临床试验中也未能降低 CVD。用不饱和脂肪替代饱和脂肪可降低低密度脂蛋白胆固醇,这是动脉粥样硬化的一个原因,将人群和临床试验中 CVD 发病的生物学证据联系起来。考虑到科学证据的整体情况,满足因果关系的严格标准,我们强烈得出结论,降低饱和脂肪摄入量并用不饱和脂肪替代,尤其是多不饱和脂肪,将降低 CVD 的发病率。正如 2013 年美国心脏协会/美国心脏病学会生活方式指南和 2015 至 2020 年美国人膳食指南所强调的,这种从饱和脂肪向不饱和脂肪的推荐转变应同时发生在总体健康的饮食模式中,如 DASH(停止高血压的饮食方法)或地中海饮食。